Cathie Wood ARK Investment Management
AUM
$13.6B
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
This Quarter Return
+34.54%
1 Year Return
+94.51%
3 Year Return
+227.41%
5 Year Return
+180.93%
10 Year Return
–
AUM
$16.9B
AUM Growth
+$16.9B
(+29%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
48.66%
Holding
228
New
2
Increased
94
Reduced
126
Closed
5
Top Buys
| 1 |
Trade Desk
TTD
|
$142M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$136M |
| 3 |
ProShares Bitcoin Strategy ETF
BITO
|
$93.2M |
| 4 |
CRISPR Therapeutics
CRSP
|
$85.9M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$77.4M |
Top Sells
| 1 |
Coinbase
COIN
|
$349M |
| 2 |
Grayscale Bitcoin Trust
GBTC
|
$108M |
| 3 |
UiPath
PATH
|
$95.8M |
| 4 |
Roku
ROKU
|
$83.5M |
| 5 |
DraftKings
DKNG
|
$81.4M |
Sector Composition
| 1 | Technology | 33.59% |
| 2 | Healthcare | 27.76% |
| 3 | Financials | 11.83% |
| 4 | Communication Services | 11.57% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coinbase
COIN
$78.1B
| $1.5B | 8.85% | 8,599,683 -2,003,881 | -19% | -$349M |
|
|
2
UiPath
PATH
$6.01B
| $1.08B | 6.39% | 43,470,597 -3,855,679 | -8% | -$95.8M |
|
3
Tesla
TSLA
$1.09T
| $945M | 5.59% | 3,802,519 -276,132 | -7% | -$68.6M |
|
|
XYZ
4
Block, Inc.
XYZ
$49B
| $920M | 5.44% | 11,887,628 +1,000,514 | +9% | +$77.4M |
|
|
5
Roku
ROKU
$14.2B
| $873M | 5.17% | 9,528,872 -910,941 | -9% | -$83.5M |
|
6
Zoom
ZM
$24.3B
| $788M | 4.67% | 10,964,576 +781,663 | +8% | +$56.2M |
|
7
Roblox
RBLX
$86.2B
| $544M | 3.22% | 11,906,173 -67,708 | -0.6% | -$3.1M |
|
8
Twilio
TWLO
$16.2B
| $541M | 3.2% | 7,130,187 -1,825 | -0% | -$138K |
|
|
9
CRISPR Therapeutics
CRSP
$4.69B
| $534M | 3.16% | 8,536,104 +1,372,986 | +19% | +$85.9M |
|
10
Unity
U
$16.5B
| $498M | 2.95% | 12,189,778 +712,579 | +6% | +$29.1M |
|
11
Shopify
SHOP
$183B
| $468M | 2.77% | 6,010,496 -944,654 | -14% | -$73.6M |
|
12
Teladoc Health
TDOC
$1.36B
| $457M | 2.71% | 21,224,565 +912,692 | +4% | +$19.7M |
|
13
Exact Sciences
EXAS
$8.84B
| $446M | 2.64% | 6,032,893 -248,038 | -4% | -$18.3M |
|
14
Robinhood
HOOD
$92B
| $445M | 2.64% | 34,936,204 +2,101,325 | +6% | +$26.8M |
|
|
15
DraftKings
DKNG
$23.7B
| $434M | 2.57% | 12,317,235 -2,310,617 | -16% | -$81.4M |
|
16
Intellia Therapeutics
NTLA
$1.21B
| $348M | 2.06% | 11,412,449 +1,463,820 | +15% | +$44.6M |
|
17
Pacific Biosciences
PACB
$396M
| $338M | 2% | 34,504,273 +4,681,833 | +16% | +$45.9M |
|
18
Ginkgo Bioworks
DNA
$731M
| $336M | 1.99% | 198,606,619 +16,414,434 | +9% | +$27.7M |
|
19
Twist Bioscience
TWST
$1.61B
| $266M | 1.57% | 7,213,257 +427,274 | +6% | +$15.7M |
|
20
PagerDuty
PD
$1.55B
| $264M | 1.56% | 11,413,423 +858,838 | +8% | +$19.9M |
|
21
Beam Therapeutics
BEAM
$1.67B
| $256M | 1.51% | 9,393,889 +609,998 | +7% | +$16.6M |
|
22
10x Genomics
TXG
$1.76B
| $226M | 1.34% | 4,041,287 +1,047,827 | +35% | +$58.6M |
|
23
Veracyte
VCYT
$2.39B
| $211M | 1.25% | 7,655,603 +62,011 | +0.8% | +$1.71M |
|
|
24
Recursion Pharmaceuticals
RXRX
$2.04B
| $204M | 1.21% | 20,654,287 +13,777,689 | +200% | +$136M |
|
25
Palantir
PLTR
$372B
| $188M | 1.11% | 10,937,859 +1,514,232 | +16% | +$26M |
|